SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-030200
Filing Date
2019-05-16
Accepted
2019-05-16 08:32:03
Documents
1
Period of Report
2019-05-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3208
  Complete submission text file 0001209191-19-030200.txt   4592
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address
McMahon Gerald PhD (Reporting) CIK: 0001290747 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38800 | Film No.: 19830609

Mailing Address 4000 SHORELINE CT #250 SOUTH SAN FRANCISCO CA 94080
Business Address 4000 SHORELINE CT #250 SOUTH SAN FRANCISCO CA 94080 650-443-7400
Harpoon Therapeutics, Inc. (Issuer) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1